Johnny Gomez
Medical · Pembroke Pines, FLNPI 1699005538
Payments from drug & device makers
Across 470 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AbbVie$1K
- Lilly USA, LLC$749
- Boehringer Ingelheim$538
- Pfizer$518
- AstraZeneca$385
- plus $4K from 33 others
What the payments were for
- Food & beverage$8,662100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 94 | $1,695 |
| AbbVie | 64 | $1,169 |
| Lilly USA, LLC | 53 | $749 |
| Boehringer Ingelheim | 32 | $538 |
| Pfizer | 25 | $518 |
| AstraZeneca | 14 | $385 |
| Biohaven Pharmaceuticals, Inc. | 22 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $248 |
| Kowa Pharmaceuticals America, Inc. | 12 | $223 |
| Bayer | 10 | $219 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $194 |
| Viiv Healthcare Company | 7 | $187 |
| Exact Sciences | 8 | $186 |
| Merck | 9 | $173 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $170 |
| Idorsia Pharmaceuticals US Inc | 7 | $156 |
| Gilead | 6 | $136 |
| Sanofi-aventis U.S. LLC | 7 | $133 |
| Abbott | 7 | $133 |
| Amarin Pharma, Inc. | 10 | $126 |
| Radius Health, Inc. | 5 | $117 |
| Amgen | 6 | $105 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $103 |
| GSK | 5 | $94 |
| Verity Pharmaceuticals Inc. | 4 | $94 |
| Almatica Pharma LLC | 4 | $91 |
| Johnson & Johnson | 3 | $58 |
| Dexcom, Inc. | 2 | $47 |
| Corcept Therapeutics | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Medtronic | 1 | $36 |
| Boston Scientific | 1 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Currax Pharmaceuticals LLC | 2 | $33 |
| Eisai Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Vivus LLC | 1 | $18 |
| IBSA Pharma Inc. | 1 | $16 |
| Exeltis, USA Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$126
- UBRELVY$125
- NURTEC ODT$109
How this compares
$8,662 in reported general payments places this provider in the 90th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 59 | $73,378 |
| OzempicSemaglutide | 58 | $57,800 |
| JardianceEmpagliflozin | 27 | $32,436 |
| EliquisApixaban | 14 | $18,373 |
| RybelsusSemaglutide | 13 | $18,304 |
| JanuviaSitagliptin Phosphate | 11 | $8,451 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $2,687 |
| SynthroidLevothyroxine Sodium | 30 | $1,755 |
| Atorvastatin Calcium | 156 | $1,462 |
| Rosuvastatin Calcium | 67 | $1,207 |
| Losartan Potassium | 90 | $822 |
| Levothyroxine Sodium | 74 | $718 |
| Amlodipine Besylate | 100 | $592 |
| Escitalopram Oxalate | 49 | $491 |
| Gabapentin | 26 | $471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,695 | $76,10471 claims |
| Lilly USA, LLCMounjaro | $749 | $73,37859 claims |
| Boehringer IngelheimJardiance | $538 | $32,43627 claims |
| PfizerEliquis | $518 | $18,37314 claims |
| MerckJanuvia | $173 | $8,45111 claims |
| AbbVieSynthroid | $1,169 | $1,75530 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,031 medical providers in Florida.
Other medical in Pembroke Pines
- Lynette Weitman NicholsonPembroke Pines$49K
- Ricardo SaizPembroke Pines$22K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.